SEXUAL WELLNESS & PIGMENTATION

PT-141

Cyclic melanocortin agonist (bremelanotide). Studied in MC4R-pathway research.

10 mgRUO · RESEARCH USE ONLY$71.99

Bundle & save

1

Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility

Free shipping

on orders over $150

Damage protection

replacement guarantee

Secure checkout

256-bit SSL

Certificate of Analysis

Third-party tested · ISO/IEC 17025 accredited

LATESTISO 170257+ TESTING

99.2%

purity

✓ Passed full QC panel

Variant
PT-141 · 10 mg
Lot #
AML-2026-0528
Labeled
10 mg
Tested
2026-04-28

Full QC panel

Purity (HPLC)
99.2%
Net Peptide Content
Pass
Identity (HPLC-MS)
Confirmed
Heavy Metals (ICP-MS)
Not detected
Sterility
No growth
Endotoxin (LAL)
Within limits
VIEW COA →

Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.

Compound Information

Chemical and structural properties

Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.

Molecular profile

Structure

CAS Number
189691-06-3
Molecular Formula
C50H68N14O10
Molecular Weight
1025.2 g/mol
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Type
Research peptide

Biological targets

Interactions

Primary target
Melanocortin receptors (MC4R, MC1R)
Pathway
MC4R–cAMP central-nervous-system signaling
Mechanism
Cyclic melanocortin-receptor agonist
Research area
Sexual-response and CNS melanocortin research

Physical properties

Handling & Storage

Appearance
White to off-white lyophilized powder
Solubility
Soluble in water; reconstitute prior to use
Storage
2-8 deg C, protect from light
Country of origin
USA

Sources & References

Peer-reviewed research

Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.

  • CURRENT OPINION IN INVESTIGATIONAL DRUGS (LONDON, ENGLAND : 2000)

    PT-141 Palatin

    2004 · PMID 15134289

    Hedlund P

    View Source ↗
  • Bremelanotide

    2012 · PMID 34436837

    View Source ↗
  • DRUGS

    Bremelanotide: First Approval

    2019 · PMID 31429064

    Dhillon S et al.

    View Source ↗
  • THE JOURNAL OF SEXUAL MEDICINE

    An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist

    2006 · PMID 16839319

    Diamond LE et al.

    View Source ↗
  • ANNALS OF THE NEW YORK ACADEMY OF SCIENCES

    PT-141: a melanocortin agonist for the treatment of sexual dysfunction

    2003 · PMID 12851303

    Molinoff PB et al.

    View Source ↗

⚠ Important research notice

PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

All the research peptides you need, with the peace of mind at your fingertips.

Research updates from Aminologix

Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.